Skip to main content
OpenTrials
Completed

NCT Number: NCT01578525

Medication Safety of Elderly Patients in Hospital and Ambulatory Setting

The purpose of this study is to determine whether additional pharmaceutical care for elderly patients (home-cared patients, nursing-home residents) has a positive impact on drug-related readmissions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Elderly Health Services for the Aged Hospital Readmission Medication Safety Pharmaceutical Care

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospital Aachen

Aachen, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient 65 years old or older
  • patient admitted to one of the project wards
  • minimum hospitalization: 3 days
  • written informed consent (patient or the legal representative)
  • current medication of the patient at hospitalization

Exclusion criteria

  • patients included in this study previously

Treatment and study plan

Pharmaceutical Care Service

Other

Checking medication under safety considerations (medication at admission, hospitalization, discharge); recommendations for potentially inappropriate medication (PRISCUS-criteria),

Primary outcomes

  1. Drug-related readmission

    Time frame: one year after discharge from the cooperating ward

Secondary outcomes

  1. Adverse drug events

    Time frame: during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward

  2. Number of prescribed potentially inappropriate medication (PRISCUS-criteria)

    Time frame: during hospital stay on cooperating wards(continuous data collection during routine ward rounds;hence,duration of data collection is dependent on individual hospital stay of each patient, up to 1 year) and 1 year after discharge from the cooperating ward

    The PRISCUS list was developed in 2010 for the German market. Potentially inappropriate medications were judged as inappropriate by an expert panel using the Delphi technique. [Holt et al., Dtsch Arztebl 2010]

  3. time to readmission

    Time frame: one year after discharge from the cooperating ward

  4. Number of accepted recommendations in the intervention group

    Time frame: during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group

  5. time for intervention

    Time frame: during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group

    time recording for pharmaceutical care service

  6. drug-related problem

    Time frame: during hospital stay on cooperating wards (continuous data collection during routine ward rounds; hence, duration of data collection is dependent on individual hospital stay of each patient, up to one year) in the intervention group

  7. number of changes in medication after discharge

    Time frame: one year

Sponsors and collaborators

Lead sponsor

RWTH Aachen University

Other

Collaborators

  • Apothekerstiftung Nordrhein, Duesseldorf
  • Foerderinitiative Pharmazeutische Betreuung e.V., Berlin

Registry information

Official study title

Medication Safety of Elderly Patients in Hospital and Ambulatory Setting Considering the Transitions of Care for Home-cared Patients and Nursing Home Residents

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Apr 17, 2012
Registry last updated
Oct 30, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.